The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027.
The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system Limitations. However, the North America injectors market is likely to have negative impact due to preference of alternative drug delivery.
In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of several chronic diseases. However, the majority of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. Treatment administration via the parenteral route is associated with concerns such as dosing errors, microbial contamination risks, and needle stick injuries. These are found to be the primary factors affecting medication adherence and, thereby affecting significantly on therapeutic outcomes. Over the years, several companies have developed advanced therapeutic delivery solutions such as wearable autoinjectors and pen injectors to overcome the challenges associated with the administration of viscous and large molecule drugs. Moreover, the concept of self-injection reduces healthcare costs and allow the optimal usage of healthcare resources.
Wearable injectors present a robust solution for increasing dosing volumes and viscosities in non-clinical settings. Specifically, large volume wearable injectors are being used for subcutaneous drug delivery and have become a preferred choice for the administration of drugs in the home-care setting. Variants of these wearable devices have been designed to administer highly viscous drugs (such as biologics) in large volumes (more than 1 mL), offering numerous dosing options, integrated safety mechanisms, and minimum risk of needle stick injuries. Besides this, it is crucial to ensure safety of healthcare providers.
North America injectors market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America injectors market – Market Segmentation
By Type
- On-body Injectors
- Off-body Injectors
By Application
- Diabetes
- Oncology
- Cardiovascular Disease
- Autoimmune Disease
- Other Applications
By End User
- Hospitals and Clinics
- Homecare Setting
- Other End User
By Country
- US
- Canada
- Mexico
Company Profiles
- BD
- CeQur SA
- Debiotech S.A
- E3D Elcam Drug Delivery Devices
- Insulet Corporation
- Gerresheimer AG
- Tandem Diabetes Care Inc
- Zealand Pharma A/S
- West Pharmaceutical Services, Inc
- Ypsomed AG
- Medtronic
- Amgen, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Wearable Injectors Market – By Type
1.3.2 North America Wearable Injectors Market – By Application
1.3.3 North America Wearable Injectors Market – By Country
2. North America Wearable Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Wearable Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Wearable Injectors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Wearable Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Chronic Diseases Prevalence
5.1.2 Technological Advancements and Design Development
5.1.3s Conventional Drug Delivery System Limitations
5.2 Key Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Increasing Demand for Biologics
5.4 Future Trends
5.4.1 Integration of Wearable Injectors During Early Drug Development
5.5 Impact analysis
6. Wearable Injectors Market – North America Analysis
6.1 North America Wearable Injectors Market Revenue Forecasts and Analysis
7. North America Wearable Injectors Market Analysis And Forecasts To 2027 – By Type
7.1 Overview
7.2 North America Wearable Injectors market, By Type 20110 & 2027 (%)
7.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 On-Body Injectors
7.3.1 Overview
7.3.2 North America On-Body Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Off-Body Injectors
7.4.1 Overview
7.4.2 North America Off-Body Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Wearable Injectors Market Analysis – By Application
8.1 Overview
8.2 North America Wearable Injectors Market, By Application 20110-2027 (%)
8.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diabetes
8.3.1 Overview
8.3.2 North America Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Oncology
8.4.1 Overview
8.4.2 North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Autoimmune Disease
8.6.1 Overview
8.6.2 North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Other Applications
8.7.1 Overview
8.7.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Wearable Injectors Market Analysis – By End User
9.1 Overview
9.2 North America Wearable Injectors Market, By End User 2019-2027 (%)
9.2.1 North America Wearable Injectors Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 North America Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Homecare Setting
9.4.1 Overview
9.4.2 North America Homecare Setting Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Other End User
9.5.1 Overview
9.5.2 North America Other End User Market Revenue and Forecasts to 2027 (US$ Mn)
10. Wearable Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Wearable Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.4 North America: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.4 North America: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
10.1.5 North America: Wearable Injectors Market, by Country, 20110 & 2027 (%)
10.1.6 US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 US: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.6.3 US: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.6.3 US: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
10.1.7 Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Canada: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.7.3 Canada: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.7.3 Canada: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
10.1.8 Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Mexico: Wearable Injectors Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Mexico: Wearable Injectors Market, by Application, 2018–2027 (USD Million)
10.1.8.3 Mexico: Wearable Injectors Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Wearable Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Wearable Injectors Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CeQur SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Debiotech S.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 E3D Elcam Drug Delivery Devices
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Insulet Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Gerresheimer AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Tandem Diabetes Care Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Zealand Pharma A/S
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 West Pharmaceutical Services, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Ypsomed AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Medtronic
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.13 Amgen, Inc.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Word Index
LIST OF TABLES
Table 1. North America Wearable Injectors Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. North America Wearable Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 1. North America Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 2. US Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. US Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 4. US Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 7. Canada Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 10. Mexico Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. List of Abbreviation
LIST OF FIGURES
Figure 1. Wearable Injectors Market Segmentation
Figure 2. Wearable Injectors Segmentation, By Region
Figure 4. On-body Injectors Segment Held Largest Share of Wearable Injectors Market
Figure 6. Wearable Injectors Market, by Geography (US$ Million)
Figure 7. Global Wearable Injectors Market – Leading Country Markets (US$ Million)
Figure 8. Global Wearable Injectors Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Wearable Injectors Market Impact Analysis of Driver and Restraints
Figure 15. Global Wearable Injectors Market – Revenue Forecast and Analysis – 2019- 2027
Figure 16. Global Wearable Injectors Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Wearable Injectors Market
Figure 18. Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
Figure 19. On-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 20. Off-body injectors: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 21. Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
Figure 22. Oncology: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 23. Diabetes: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 24. Autoimmune Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 25. Cardiovascular Disease: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 26. Other Applications: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 27. Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
Figure 28. Homecare Setting: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 29. Hospitals and Clinics: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 30. Other End Users: Wearable Injectors Market Market– Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Wearable Injectors Market, by Country, 2019 & 2027 (%)
Figure 34. US: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Canada Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Figure 37. Mexico: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of Covid-19 Pandemic In North American Country Markets
- B. Braun Melsungen ag
- Smith & Nephew
- Mölnlycke Health Care AB
- Convatec Inc
- BD
- Cardinal Health Inc.
- Schülke and Mayr
- Coloplast Corp
- Reckitt Benckiser Group plc
- Serag-Wiessner Gmbh and CO.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For